Chimeric Therapeutics (ASX:CHM) - Webinar Presentation

Company Presentations

by Finance News Network

Jennifer Chow - CEO - Chimeric Therapeutics (ASX:CHM) is a clinical-stage therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. 

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?